CSL Limited - SIC # 6794 - PATENT OWNERS AND LESSORS

Ticker Exchange SIC # Website Latest Ticker
CSLLY Over the counter 6794 www.csl.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for CSL Limited

HRMY vs. CSLLY: Which Stock Is the Better Value Option? - Oct 6th, 2026 8:40 am
CSL (ASX:CSL) Could Be 15% Undervalued After Its $355 Million Alentis Deal - Oct 6th, 2026 4:07 am
CSL to pay up to $1.6 bln to develop rare disease drug; shares rise - Oct 4th, 2026 7:23 pm
CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases - Oct 4th, 2026 3:46 pm
CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign - Sep 29th, 2026 7:30 am
Former Gilead CIO and CSL Chief Digital & Information Officer Mark Hill Joins Sware Board of Directors - Sep 29th, 2026 7:00 am
Why Is CSL (ASX:CSL) Launching Its New Flu Vaccine First In The UK? - Sep 22nd, 2026 6:18 pm
Expanded ANDEMBRY Reimbursement In Canada Could Be A Game Changer For CSL (ASX:CSL) - Sep 22nd, 2026 11:12 am
Public Access to ANDEMBRY® (garadacimab) Expands Across Canada for the Prevention of Hereditary Angioedema (HAE) Attacks - Sep 22nd, 2026 6:00 am
Lancet Publication Marks Important Advance in Influenza Prevention for Older Adults - Sep 10th, 2026 4:40 pm
CSL Ltd's Dividend Analysis - Sep 10th, 2026 5:05 am
Trump's MFN Push Goes Beyond Big Pharma, Adds 9 Mid-Sized Drugmakers - Sep 1st, 2026 10:35 am
CSL Reports Positive Top-Line Phase 3b Results Supporting Planned Expanded Pediatric Filing for ANDEMBRY® (garadacimab-gxii) in Children with Hereditary Angioedema (HAE) - Jul 27th, 2026 7:00 am
CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union - Jun 26th, 2026 7:00 am